Representative before the EPO

Technology company logo thumb
no operation time available
1 office
Technology Company

Representative before the EPO

Technology company logo thumb
no operation time available
1 office
Technology Company

Nicolas Favre has worked on the following 27 EPO patent applications which have been published in the last five years:

EP11706611

SMOC1, TENASCIN-C AND BRAIN CANCERS

IPC classification:
A61K 39/395, A61P 35/00, C07K 16/18, C12N 15/113
Applicant:
Friedrich Miescher Institute For Biomedical Research
Agent:
Nicolas Favre, Novartis Pharma AG
Status:
EXAMINATION IN PROGRESS
EP11712218

PROTEIN TYROSINE PHOSPHATASE, NON-RECEPTOR TYPE 11 (PTPN11) AND TUMOR INITIATING CELLS

IPC classification:
A61K 31/65, A61K 38/00, A61K 39/00, A61P 35/00
Applicant:
Friedrich Miescher Institute For Biomedical Research
Agent:
Nicolas Favre, Novartis Pharma AG
Status:
EXAMINATION IN PROGRESS
EP11714985

MODULATING XRN1

IPC classification:
C12N 15/113
Applicant:
Friedrich Miescher Institute For Biomedical Research
Agent:
Nicolas Favre, Novartis Pharma AG
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP12714337

CULTURE MEDIUM SUITABLE FOR THE CULTURE OF UNDIFFERENTIATED CELLS

IPC classification:
C12N 5/00, C12N 5/071
Applicant:
Novartis Forschungsstiftung
Agent:
Nicolas Favre, Friedrich Miescher Institute For Biomedical Research
Status:
APPLICATION WITHDRAWN
EP12725781

PROTEIN TYROSINE PHOSPHATASE, NON-RECEPTOR TYPE 11 (PTPN11) AND TRIPLE-NEGATIVE BREAST CANCER

IPC classification:
A61K 39/395, A61K 48/00, A61P 35/00, C07K 16/30
Applicant:
Friedrich Miescher Institute For Biomedical Research
Applicant:
Novartis Forschungsstiftung
Agent:
Nicolas Favre, Friedrich Miescher Institute For Biomedical Research
Status:
GRANT OF PATENT INTENDED
EP12791128

ROD CELL-SPECIFIC PROMOTER

IPC classification:
A61K 48/00, C07K 14/475, C12N 5/10, C12N 15/79
Applicant:
Friedrich Miescher Institute For Biomedical Research
Agent:
Nicolas Favre, Friedrich Miescher Institute For Biomedical Research
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP12781128

EARLY DIAGNOSTIC OF NEURODEGENERATIVE DISEASES

IPC classification:
G01N 33/68
Applicant:
Friedrich Miescher Institute For Biomedical Research
Agent:
Nicolas Favre, Friedrich Miescher Institute For Biomedical Research
Status:
GRANT OF PATENT INTENDED
EP13712296

INHIBITION OF INTERLEUKIN- 8 AND/OR ITS RECEPTOR CXCRL IN THE TREATMENT HER2/HER3 -OVEREXPRESSING BREAST CANCER

IPC classification:
C07K 16/24, C07K 16/28
Applicant:
Friedrich Miescher Institute For Biomedical Research
Agent:
Nicolas Favre, Friedrich Miescher Institute For Biomedical Research
Status:
EXAMINATION IN PROGRESS
EP11754420

PHOSPHORYLATED TWIST1 AND METASTASIS

IPC classification:
A61K 38/17, A61P 35/04, C07K 16/18
Applicant:
Friedrich Miescher Institute For Biomedical Research
Agent:
Nicolas Favre, Novartis Pharma AG
Status:
APPLICATION WITHDRAWN
EP13732495

TREATING DISEASES BY MODULATING A SPECIFIC ISOFORM OF MKL1

IPC classification:
A61K 39/00, A61K 39/395
Applicant:
Friedrich Miescher Institute For Biomedical Research
Agent:
Nicolas Favre, Friedrich Miescher Institute For Biomedical Research
Status:
EXAMINATION REQUESTED
EP13734067

NEW TREATMENT FOR NEURODEGENERATIVE DISEASES

IPC classification:
A61K 38/50, A61K 39/00, A61K 48/00, C12N 9/80
Applicant:
Friedrich Miescher Institute For Biomedical Research
Agent:
Nicolas Favre, Friedrich Miescher Institute For Biomedical Research
Status:
GRANT OF PATENT INTENDED
EP13756391

RETINAL OFF CIRCUIT-SPECIFIC PROMOTER

IPC classification:
A61K 48/00, A61P 27/02, C12N 5/079, C12N 15/85, C12N 15/86
Applicant:
Friedrich Miescher Institute For Biomedical Research
Agent:
Nicolas Favre, Friedrich Miescher Institute For Biomedical Research
Status:
EXAMINATION IN PROGRESS
EP11725716

TREATING CANCER BY MODULATING MAMMALIAN STERILE 20-LIKE KINASE 3

IPC classification:
A61P 35/00, C07K 16/00, C07K 16/30
Applicant:
Friedrich Miescher Institute For Biomedical Research
Agent:
Nicolas Favre, Novartis Pharma AG
Status:
APPLICATION WITHDRAWN
EP14706119

NOVEL METHODS FOR THE TARGETED INTRODUCTION OF VIRUSES INTO CELLS

IPC classification:
C12N 7/00, C12N 15/87
Applicant:
Federal Institute of Technology Zurich (Eidgenössische Technische Hochschule Zürich)
Applicant:
Friedrich Miescher Institute For Biomedical Research
Agent:
Nicolas Favre, Friedrich Miescher Institute For Biomedical Research
Status:
EXAMINATION IN PROGRESS
EP14715425

METHOD FOR THE GENERATION OF POLYCYSTRONIC VECTORS

IPC classification:
C12N 15/64, C12N 15/66
Applicant:
Friedrich Miescher Institute For Biomedical Research
Agent:
Nicolas Favre, Friedrich Miescher Institute For Biomedical Research
Status:
EXAMINATION IN PROGRESS
EP14736451

ELECTRICALLY CONDUCTIVE SAMPLE BLOCKS FOR SCANNING ELECTRON MICROSCOPY

IPC classification:
G01N 1/00, G01N 1/36, H01J 37/00, H01J 37/20
Applicant:
Friedrich Miescher Institute For Biomedical Research
Agent:
Nicolas Favre, Friedrich Miescher Institute For Biomedical Research
Status:
GRANT OF PATENT INTENDED
EP14732978

RETINAL ON BIPOLAR CELLS-SPECIFIC ARTIFICIAL PROMOTER

IPC classification:
A61K 48/00, C12N 15/85, C12N 15/861
Applicant:
Friedrich Miescher Institute For Biomedical Research
Agent:
Nicolas Favre, Friedrich Miescher Institute For Biomedical Research
Status:
EXAMINATION IN PROGRESS
EP11781557

ANTI-FUNGAL AGENTS

IPC classification:
C07K 14/37, C12N 15/80, C12N 15/81
Applicant:
ETH Transfer
Applicant:
Friedrich Miescher Institute For Biomedical Research
Agent:
Nicolas Favre, Novartis Pharma AG
Agent:
Nicolas Favre, Friedrich Miescher Institute For Biomedical Research
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP14780581

NEW SCREENING METHOD FOR THE TREATMENT FRIEDREICH'S ATAXIA

IPC classification:
C12Q 1/68, G01N 33/50
Applicant:
Friedrich Miescher Institute For Biomedical Research
Applicant:
Novartis AG
Agent:
Nicolas Favre, Friedrich Miescher Institute For Biomedical Research
Status:
EXAMINATION IN PROGRESS
EP15709745

MÜLLER CELL-SPECIFIC PROMOTER

IPC classification:
A61K 48/00, C12N 15/85
Applicant:
Friedrich Miescher Institute For Biomedical Research
Agent:
Nicolas Favre, Friedrich Miescher Institute For Biomedical Research
Status:
EXAMINATION REQUESTED
EP15709743

AII RETINAL AMACRINE CELL-SPECIFIC PROMOTER

IPC classification:
A61K 48/00, C12N 15/85
Applicant:
Friedrich Miescher Institute For Biomedical Research
Agent:
Nicolas Favre, Friedrich Miescher Institute For Biomedical Research
Status:
EXAMINATION REQUESTED
EP15714022

PREDICTION OF PREECLAMPSIA USING MICRORNA

IPC classification:
C12Q 1/68
Applicant:
University Hospital Basel (Universitätsspital Basel)
Applicant:
Friedrich Miescher Institute For Biomedical Research
Agent:
Nicolas Favre, Friedrich Miescher Institute For Biomedical Research
Status:
EXAMINATION REQUESTED
EP15750455

COMBINATION OF A BRAFV600E INHIBITOR AND MERTK INHIBITOR TO TREAT MELANOMA

IPC classification:
A61K 31/437, A61K 31/4706, A61K 31/506, A61P 35/00
Applicant:
Friedrich Miescher Institute For Biomedical Research
Agent:
Nicolas Favre, Friedrich Miescher Institute For Biomedical Research
Status:
EXAMINATION REQUESTED
EP15778746

LATS AND BREAST CANCER

IPC classification:
A61K 31/138, A61K 39/395, A61K 48/00, A61P 35/00, C12N 15/113
Applicant:
Friedrich Miescher Institute For Biomedical Research
Agent:
Nicolas Favre, Friedrich Miescher Institute For Biomedical Research
Status:
Request for examination was made

Please Sign in to use this feature